Business
Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange
Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange Canada NewsWire ...
About this update from Cannara Biotech, Inc.
[{"type":"text","content":"\n\n\n\nCannara Biotech Shares to Begin Trading on the Frankfurt Exchange\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONTRÉAL, Feb. 11, 2019\n\n\n\nMONTRÉAL, Feb. 11, 2019 /CNW/ - Cannara Biotech Inc. (\"Cannara Biotech\" or the \"Company\") (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol \"8CB\". The Company's common shares continue to be listed on the Canadian Securities Exchange under the trading symbol \"LOVE\".  \nThe Frankfurt Stock Exchange is the tenth largest stock exchange in the world by market capitalization and third largest in terms of volume. It is Germany's largest stock exchange.\n\"No doubt the world is becoming keenly interested in the global cannabis industry, and much of that enthusiasm and attention is turning towards Canadian companies who are at the forefront of innovating and leading this sector,\" said Zohar Krivorot, President and CEO of Cannara Biotech. \"For Cannara Biotech, whose vision is to be a premium global cannabis company, this international listing will enable us to broaden our shareholder base, while allowing international investors to participate in our growth.\"\nThe Canadian cannabis market is forecasted at $5.2B in year one of legalization and is expected growth of 20% annually to reach $10.8B in five years.\nAbout Cannara Biotech Inc.\nCannara Biotech is building one of the largest indoor cannabis cultivation facility (625,000 square foot) in Canada and the largest in Quebec. Leveraging Quebec's low electricity costs, Cannara Biotech's facility will produce high-grade indoor cannabis and cannabis-infused products for the Canadian and international markets. Most recently, the Company entered the U.S. CBD-hemp market with an online eCommerce platform called shopCBD.com, which will also make the Company an aggregator of U.S. CBD-hemp products. For more information, visit our websit...